BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Abionyx Pharma S.A.

Headquarters: Balma, Cedex, France
Year Founded: 2005
Status: Public
Industry Sector: HealthTechnology
CEO: Cyrille Tupin, CPA
Number Of Employees: 51
Enterprise Value: $41,276,308
PE Ratio: -30.66
Exchange/Ticker 1: Euronext Paris:ABNX
Exchange/Ticker 2: N/A
Latest Market Cap: $162,287,833

BioCentury | Jul 30, 2024
Product Development

Venturing beyond AAVs and LNPs to deliver therapeutic cargo

Dozens of companies aim to avoid immunogenicity and improve tissue-specificity
BioCentury | Jan 15, 2022
Finance

4Q21 Wrap: the bleeding continues

Biopharmas continued to slump in 4Q21 across all market cap tiers
BioCentury | Dec 3, 2021
Distillery Therapeutics

An APOA1 mimic peptide for silica-induced cardiovascular damage

BioCentury | Apr 7, 2017
Finance

Fade to black

Biotech winners, losers in 1Q17
Items per page:
1 - 4 of 4